Literature DB >> 25870481

Dermatomycosis frequency and localization sites.

Allma Ferizi Koçinaj1, Merita Grajqevci Kotori1, Andi Koraqi2, Monika Fida2.   

Abstract

INTRODUCTION: Since the prevalence of skin mycotic infections is changing and is area depended we aimed to analyze the frequency of the skin myocotic infections and the appearance sites.
MATERIAL AND METHODS: There were involved 560 patients referred to the Dermatology Clinic of University Clinical Center of Kosova during a period of one year.
RESULTS: The mean age of our study group was around thirties with a predominance of female and rural patients. Although most of cases presented with single site disease localization, we observed the increase in number of cases with more than one site localization with age.
CONCLUSION: The increased prevalence skin mycotic infections, as well as more than one place of localization deserve a multidimensional approach.

Entities:  

Keywords:  infection; mycotic

Mesh:

Year:  2015        PMID: 25870481      PMCID: PMC4384832          DOI: 10.5455/medarh.2015.69.58-59

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


1. INTRODUCTION

Mycotic infections of the skin, nails and hair are frequent. Their epidemiological features change and are not similar according to the different geographical area. The prevalence of skin mycotic infections is changing with age, geographic location and climate (1, 2). Despite regional characteristics and predispositions for dermatophyte infections, the spectrum of dermatophytes is not static(3). The infection can be caused by dermatophyte, yeast and non-dermatophyte agents. The epidemiology of dermatophyte infection has changed as a result of migration, lifestyle, drug therapy, and socioeconomic conditions (4). The aim of our study was to analyze the appearance sites and frequency of the skin myocotic infections.

2. METHODOLOGY

We included patients visited in out- inpatient departments of the Dermatology Clinic of University Clinical Center of Kosova during one calendar year. We studied the prevalence of mycosis involving 560 patients referred to the Dermatology Clinic of University Clinical Center of Kosova during 2011 year.

2.1. Study population

The study population included all ages with the youngest a newborn patient and the oldest patient over 75 years; both genders, with slightly less presented males 46.5%. The study group was also analyzed according to the site localization.

3. RESULTS

The mean age of our study group was 30.82±17.69 with the oldest patient of 77 years. There was a predominance of women diagnosed with skin mycology changes 53.4% and also a predominance of patients from rural places 58.2%. Basic characteristics of the study population. *Except the average age and SD other values are presented by number and percentage The great percentage of referred patients had single site localization 94.8% whereas there were also those with multiple site of the disease localization, double (4.8%) respectively triple (0.4%) site. Affected sites noticed at our study population We have analyzed also the sites that were affected by skin changes in particular in those who had more than one site and also whether the involvement of multiple sites were related to age, gender or living place. There was shown a very low correlation between age and single or multiple sites of localization while very low negative correlation was found between living place and single or multiple sites of localization too. The correlation between number of disease sites and some basic modalities The Correlation between living place, age and sites of localization

4. DISCUSSION

Fungi are everywhere and no geographical area or any group of people is spared by these organisms (5). However this study is very useful to determine the size of the problem, prevention of these infections and protocols of the treatment. In our study we found that the highest incidence of mycotic infections occur in females same as in other studies (6, 7).

5. CONCLUSION

The increased prevalence of mycosis- skin manifestations as well as more frequent tinea pedis and tinea unguium deserves an improved approach toward these diseases. More frequent presence of skin mycotic infections in particular the multiple sites of their localization rises priorities of taking simple measures like education activities for whole population, special population categories and also activities for updating and upgrading health caregivers knowledge about diagnoses and treatment of these entities.
Table 1

Basic characteristics of the study population. *Except the average age and SD other values are presented by number and percentage

Table 2

Affected sites noticed at our study population

Table 3

The correlation between number of disease sites and some basic modalities

  6 in total

1.  The extra-human occurrence of Trichophyton tonsurans var. sulfureum in a residential school.

Authors:  D W MACKENZIE
Journal:  Sabouraudia       Date:  1961-01

Review 2.  Epidemiology of superficial fungal infections.

Authors:  Mahreen Ameen
Journal:  Clin Dermatol       Date:  2010-03-04       Impact factor: 3.541

3.  Etiologic agents of dermatophyte infection in Lebanon.

Authors:  George F Araj; Eddie S Racoubian; Nemat K Daher
Journal:  J Med Liban       Date:  2004 Apr-Jun

Review 4.  Epidemiological trends in skin mycoses worldwide.

Authors:  Blanka Havlickova; Viktor A Czaika; Markus Friedrich
Journal:  Mycoses       Date:  2008-09       Impact factor: 4.377

5.  Characteristics of superficial mycoses in Malta.

Authors:  Loranne Vella Zahra; Paul Gatt; Michael J Boffa; Eileen Borg; Edwin Mifsud; Lawrence Scerri; Dino Vella Briffa; Joseph L Pace
Journal:  Int J Dermatol       Date:  2003-04       Impact factor: 2.736

6.  Superficial fungal infections: clinical and epidemiological study in adolescents from marginal districts of Lima and Callao, Peru.

Authors:  Juan Medina Flores; Vilma Bejar Castillo; Florencio Cortez Franco; Armando Betanzos Huata
Journal:  J Infect Dev Ctries       Date:  2009-05-01       Impact factor: 0.968

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.